Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus–infected patients treated for non-Hodgkin lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2002-01, Vol.99 (2), p.724-725
Hauptverfasser:	Persico, Marcello, De Marino, Fedele, Russo, Giovanni Di Giacomo, Severino, Alessandro, Palmentieri, Bruno, Picardi, Marco, Morante, Aristide, Rotoli, Bruno, Torella, Roberto, De Renzo, Amalia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Comorbidity Drug Evaluation Female Hepacivirus - drug effects Hepacivirus - physiology Hepatitis B virus - drug effects Hepatitis B virus - physiology Hepatitis B, Chronic - complications Hepatitis B, Chronic - epidemiology Hepatitis C - complications Hepatitis C - epidemiology Humans Immunocompromised Host Lamivudine - pharmacology Lamivudine - therapeutic use Liver Function Tests Lymphoma, Non-Hodgkin - complications Lymphoma, Non-Hodgkin - drug therapy Male Middle Aged Prevalence Reverse Transcriptase Inhibitors - pharmacology Treatment Outcome Virus Activation - drug effects Virus Replication - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!